# abrdn Life Sciences Investors: Form SCHEDULE 13D/A, filed Apr 1, 2025

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-01
- Accepted by EDGAR: Apr 2, 2025, 01:49 ET
- Period: not reported
- Accession: 0001062993-25-006767
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000106299325006767/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000106299325006767/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000106299325006767/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001062993-25-006767. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.